Xebra Brands Ltd. (XBRA) AI Stock Analysis

• Market Cap: C$1.50M
• Dividend Yield: N/A
• Average Volume (3M): 117.20K
• Price to Earnings (P/E): ―
• Beta (1Y): -2.06
• Revenue Growth: -100.00%
• EPS Growth: 43.66%
• Country: CA
• Employees: N/A
• Sector: Healthcare
• Sector Strength: 40
• Industry: Drug Manufacturers - Specialty & Generic
• EPS (TTM): N/A
• Shares Outstanding: 75,181,940
• 10 Day Avg. Volume: 133,230
• 30 Day Avg. Volume: 117,203
• PEG Ratio: 0.81
• Price to Book (P/B): 28.02
• Price to Sales (P/S): 0.00
• P/FCF Ratio: -3.61
• Enterprise Value/Market Cap: N/A
• Enterprise Value/Revenue: N/A
• Enterprise Value/Gross Profit: N/A
• Enterprise Value/Ebitda: N/A
• 1Y Price Target: N/A
• Price Target Upside: N/A
• Rating Consensus: N/A
• Number of Analyst Covering: 0

• Rating: 49 Neutral
• Price Target: ―

Xebra Brands Ltd. scores 48.75, reflecting significant financial struggles, including high liabilities and negative cash flows. However, recent strategic corporate events, such as market expansions and regulatory achievements, provide potential growth opportunities. The technical analysis suggests upward momentum but warns of overbought conditions.

Xebra Brands Ltd. Business Overview & Revenue Model

Company Description

Xebra Brands Ltd. engages in the cultivation, processing, manufacturing, design, and delivery of cannabis products in Canada. It provides cannabis infused beverages, including seltzers, soft drinks, iced teas, lemonades, waters, and energy and sport drinks; and wellness products that include capsules, tinctures, topicals, and intimate oils for personal care. The company offers its products under the HighJack, MadCap, Vicious Citrus, Conquer, HolaHi, and HighCastle brands. Xebra Brands Ltd. was incorporated in 2019 and is headquartered in Vancouver, Canada.

How the Company Makes Money

Xebra Brands Ltd. generates revenue through the cultivation, production, and sale of cannabis products. The company's primary revenue streams include the sale of cannabis flowers, oils, and infused products to both medical and recreational consumers. Xebra Brands also engages in licensing agreements and partnerships that allow it to expand its market reach and product offerings. By securing strategic partnerships with local and international distributors, the company enhances its ability to enter new markets and drive sales. Additionally, Xebra Brands invests in research and development to innovate and improve its product line, aiming to capture a larger share of the growing cannabis market.

Xebra Brands Ltd. Financial Statement Overview

Summary

Xebra Brands Ltd. is experiencing significant financial challenges, including unprofitability, declining equity, and negative cash flows. The company struggles with revenue generation and maintaining a stable financial structure.

Income Statement

Xebra Brands Ltd. has consistently faced challenges in generating revenue, with the most recent TTM (Trailing-Twelve-Months) revenue at a mere $1. The company has negative gross and net profit margins, indicating unprofitability. Despite a significant reduction in EBIT and EBITDA losses from previous periods, the company struggles to cover its operating costs.

Balance Sheet

The company's balance sheet shows a high level of liabilities compared to equity, resulting in a negative stockholders' equity in recent years. With no debt, the debt-to-equity ratio is not applicable, but the low equity indicates financial instability. The equity ratio has significantly decreased, reflecting the eroding asset base.

Cash Flow

Xebra Brands Ltd. has negative operating and free cash flows, indicating continuing cash burn without sufficient revenue generation. The recent reduction in negative cash flow is a positive sign, but the operating cash flow to net income ratio remains unfavorable, highlighting ongoing liquidity challenges.

Breakdown	Mar 2024	Mar 2023	Mar 2022	Mar 2021	Mar 2020
Income Statement
Total Revenue	106.86K	158.95K	0.00	0.00	0.00
Gross Profit	-308.42K	-16.03K	-603.37K	-550.31K	-11.78K
EBITDA	-1.49M	-2.82M	-3.93M	-1.28M	-2.78M
Net Income	-1.96M	-4.02M	-6.14M	-1.86M	-2.79M
Balance Sheet
Total Assets	379.37K	1.32M	1.32M	3.60M	5.14M
Cash, Cash Equivalents and Short-Term Investments	102.42K	202.29K	202.29K	93.33K	955.41K
Total Debt	0.00	0.00	28.79K	67.03K	321.27K
Total Liabilities	789.96K	772.16K	772.16K	618.85K	610.72K
Stockholders Equity	-154.52K	795.67K	795.67K	3.00M	4.54M
Cash Flow
Free Cash Flow	-827.56K	-2.39M	-2.39M	-1.06M	-2.28M
Operating Cash Flow	-827.56K	-2.32M	-2.32M	-911.32K	-1.96M
Investing Cash Flow	0.00	-63.63K	-63.63K	-145.28K	-1.57M
Financing Cash Flow	722.64K	1.94M	1.94M	201.60K	4.48M

Xebra Brands Ltd. Technical Analysis

• Technical Analysis Sentiment: Negative
• Last Price: 0.02
• 50DMA: Negative
• 100DMA: Negative
• 200DMA: Negative
• MACD: Negative
• RSI: Positive
• STOCH: Neutral

Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For TSE:XBRA, the sentiment is Negative. The current price of 0.02 is below the 20-day moving average (MA) of 0.03, below the 50-day MA of 0.04, and below the 200-day MA of 0.05, indicating a bearish trend. The MACD of >-0.01 indicates Negative momentum. The RSI at 26.52 is Positive, neither overbought nor oversold. The STOCH value of 38.89 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for TSE:XBRA.

Xebra Brands Ltd. Peers Comparison

Name	Overall Rating	Market Cap	P/E Ratio	ROE	Dividend Yield	Revenue Growth	EPS Growth
Sector *	52 Neutral	$7.39B	>-0.01	-63.86%	2.36%	16.15%	0.36%
XBRA	49 Neutral	C$1.50M	―	-542.08%	―	-100.00%	43.66%
WIB	―	C$1.96M	―		―	―	―
THCBF	―	$2.39M	―		―	―	―
BHHKF	―	$1.94M	―		―	―	―
VENI	40 Underperform	C$1.39M	―	-21.61%	―	―	―
AION	31 Underperform	C$2.42M	―		―	563.34%	-68.82%

Xebra Brands Ltd. Corporate Events

Xebra Brands Expands into U.S. CBD Market with BSK Partnership

Xebra Brands Ltd. has announced an expanded partnership with BSK Holdings Inc. to launch its Elements branded CBD products in the United States, marking a significant step into the world’s largest hemp and CBD market. This strategic move aims to leverage BSK’s established network and expertise in the U.S. market, positioning Elements in wellness and active lifestyle verticals. The collaboration is expected to enhance Xebra’s market presence in North America, complementing its leadership in the Mexican CBD market and aligning with its vision to establish Elements as a trusted North-American brand.

Xebra Brands Secures Dutch Cannabis License, Eyes European Expansion

Xebra Brands Ltd. has been granted a Dutch cannabis cultivation license for scientific research, marking a significant milestone for its European operations. This license allows Xebra to legally cultivate and process cannabis in the Netherlands, a country recognized for its pioneering cannabis regulation. The company is exploring strategic opportunities such as cannabis genetics R&D, strategic partnerships, product innovation, and export opportunities to monetize this license and expand its market presence across Europe.

Xebra Brands Partners with BSK Holdings to Launch CBD Products in Mexico

Xebra Brands Ltd. has announced a strategic partnership with BSK Holdings Inc. to launch its Elements branded CBD products in the Mexican market through a robust e-commerce platform. This collaboration leverages BSK’s extensive experience and success in the CBD and hemp markets in the US and Canada, aiming to capitalize on Mexico’s rapidly growing e-commerce sector. The partnership is expected to create a strong synergy that will drive the growth and success of Xebra’s Elements brand in Mexico, positioning the company to expand further into the US market.

Xebra Brands Embraces Regulatory Shift in Mexico’s Cannabis Market

Xebra Brands Ltd. has welcomed a significant announcement from Mexico’s Federal Commission for the Protection against Sanitary Risks (COFEPRIS), which condemns the illegal marketing of unregulated CBD and cannabis-derived products. This marks a pivotal shift towards strict enforcement of cannabis regulations in Mexico, reinforcing Xebra’s unique position as the sole company with legal federal authorizations. The company is engaging with affected brands to help them transition into the formal market, aiming to ensure compliance and consumer safety in the evolving cannabis sector.

Xebra Brands Unveils Strategic Plan to Boost North American CBD Market Presence

Xebra Brands Ltd. has announced its Strategic 2025 Roadmap aimed at expanding its presence in the North American CBD market. This plan, developed with a specialized consulting firm, focuses on domestic cultivation, manufacturing partnerships, and rapid retail distribution to capitalize on the growing CBD market, which is expected to see significant growth due to increasing legalization and consumer demand.

Xebra Brands Finalizes Shares-for-Debt Transaction as Strategic Financial Move

Xebra Brands Ltd. has finalized a shares-for-debt transaction to settle $448,146 in accrued liabilities by issuing 8,962,917 common shares, allowing the company to preserve funds for operational growth. This move, involving related party transactions, is subject to Canadian Securities Exchange approval and follows Xebra’s plans for a private placement to raise additional capital, reflecting strategic financial management to strengthen its market position.

Xebra Brands Announces Strategic Financial Moves

Xebra Brands Ltd. has announced a non-brokered private placement aiming to raise up to $150,000 by issuing 3,000,000 units at $0.05 per unit. Additionally, the company plans to settle $450,000 of debt by issuing 9,000,000 common shares to preserve funds for operations and growth, subject to regulatory approvals. This strategic move is expected to improve the company’s financial stability and facilitate further expansion.